These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 12359758

  • 1. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M, Küpcü Z, Schüller S, Zalusky D, Zehetner M, Paster W, Schweighoffer T.
    Cancer Res; 2002 Oct 01; 62(19):5489-94. PubMed ID: 12359758
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 01; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 3. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
    Singh R, Paterson Y.
    Cancer Res; 2006 Aug 01; 66(15):7748-57. PubMed ID: 16885378
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov 01; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T, Steitz J, Brück J, Gambotto A, Steinbrink K, DeLeo AB, Robbins P, Knop J, Enk AH.
    J Gene Med; 1999 Nov 01; 1(6):400-6. PubMed ID: 10753065
    [Abstract] [Full Text] [Related]

  • 6. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
    Tan XH, Liu C, Wan YH.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 01; 28(9):658-61. PubMed ID: 17274369
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA, Orsini C, Lindinger P, Thalhamer J, Abrams SI.
    Cell Immunol; 2000 Nov 01; 205(2):73-83. PubMed ID: 11104579
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.
    Goldberg SM, Bartido SM, Gardner JP, Guevara-Patiño JA, Montgomery SC, Perales MA, Maughan MF, Dempsey J, Donovan GP, Olson WC, Houghton AN, Wolchok JD.
    Clin Cancer Res; 2005 Nov 15; 11(22):8114-21. PubMed ID: 16299244
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 13. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
    Vaccine; 2009 Jun 08; 27(28):3692-6. PubMed ID: 19428161
    [Abstract] [Full Text] [Related]

  • 14. Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.
    Steitz J, Tormo D, Schweichel D, Tüting T.
    Cancer Gene Ther; 2006 Mar 08; 13(3):318-25. PubMed ID: 16151477
    [Abstract] [Full Text] [Related]

  • 15. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
    Conforti A, Peruzzi D, Giannetti P, Biondo A, Ciliberto G, La Monica N, Aurisicchio L.
    J Immunother; 2009 Sep 08; 32(7):744-54. PubMed ID: 19561534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
    Tormo D, Ferrer A, Bosch P, Gaffal E, Basner-Tschakarjan E, Wenzel J, Tüting T.
    Cancer Res; 2006 May 15; 66(10):5427-35. PubMed ID: 16707471
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
    Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van Hall T, Offringa R, Figdor CG, Adema GJ.
    Cancer Res; 2000 Dec 15; 60(24):6995-7001. PubMed ID: 11156402
    [Abstract] [Full Text] [Related]

  • 20. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
    Mennuni C, Ugel S, Mori F, Cipriani B, Iezzi M, Pannellini T, Lazzaro D, Ciliberto G, La Monica N, Zanovello P, Bronte V, Scarselli E.
    Cancer Res; 2008 Dec 01; 68(23):9865-74. PubMed ID: 19047167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.